New England Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.33M | Buy |
40,464
+428
| +1% | +$24.6K | 0.27% | 76 |
|
|
2026
Q1 | $2.43M | Hold |
40,036
| – | – | 0.31% | 73 |
|
|
2025
Q4 | $2.16M | Hold |
40,036
| – | – | 0.28% | 72 |
|
|
2025
Q3 | $1.81M | Buy |
40,036
+315
| +0.8% | +$14.7K | 0.24% | 82 |
|
|
2025
Q2 | $1.84M | Buy |
39,721
+245
| +0.6% | +$12K | 0.29% | 79 |
|
|
2025
Q1 | $2.41M | Buy |
39,476
+305
| +0.8% | +$17.8K | 0.39% | 75 |
|
|
2024
Q4 | $2.22M | Sell |
39,171
-7,600
| -16% | -$425K | 0.38% | 77 |
|
|
2024
Q3 | $2.42M | Buy |
46,771
+1,330
| +3% | +$62.4K | 0.38% | 75 |
|
|
2024
Q2 | $1.89M | Sell |
45,441
-1,235
| -3% | -$55.3K | 0.31% | 74 |
|
|
2024
Q1 | $2.53M | Sell |
46,676
-530
| -1% | -$27K | 0.39% | 70 |
|
|
2023
Q4 | $2.42M | Sell |
47,206
-32,325
| -41% | -$1.7M | 0.39% | 73 |
|
|
2023
Q3 | $4.62M | Sell |
79,531
-2,000
| -2% | -$123K | 0.76% | 49 |
|
|
2023
Q2 | $5.21M | Hold |
81,531
| – | – | 0.76% | 46 |
|
|
2023
Q1 | $5.65M | Sell |
81,531
-4,865
| -6% | -$343K | 0.84% | 43 |
|
|
2022
Q4 | $6.22M | Sell |
86,396
-100
| -0.1% | -$7.54K | 0.11% | 41 |
|
|
2022
Q3 | $6.15M | Sell |
86,496
-22,675
| -21% | -$1.64M | 0.1% | 39 |
|
|
2022
Q2 | $8.41M | Buy |
109,171
+700
| +0.6% | +$53.3K | 0.14% | 27 |
|
|
2022
Q1 | $7.92M | Buy |
108,471
+1,200
| +1% | +$80.6K | 0.13% | 31 |
|
|
2021
Q4 | $6.69M | Buy |
107,271
+9,800
| +10% | +$575K | 0.1% | 34 |
|
|
2021
Q3 | $5.77M | Buy |
97,471
+29,021
| +42% | +$1.91M | 0.1% | 37 |
|
|
2021
Q2 | $4.57M | Buy |
68,450
+2,450
| +4% | +$160K | 0.08% | 43 |
|
|
2021
Q1 | $4.17M | Buy |
66,000
+1,350
| +2% | +$84K | 0.08% | 48 |
|
|
2020
Q4 | $4.01M | Buy |
64,650
+1,600
| +3% | +$98.4K | 0.08% | 45 |
|
|
2020
Q3 | $3.8M | Sell |
63,050
-2,250
| -3% | -$135K | 0.09% | 45 |
|
|
2020
Q2 | $3.84M | Sell |
65,300
-5,700
| -8% | -$341K | 0.09% | 41 |
|
|
2020
Q1 | $3.96M | Buy |
71,000
+4,300
| +6% | +$263K | 0.09% | 39 |
|
|
2019
Q4 | $4.28M | Sell |
66,700
-1,050
| -2% | -$60.1K | 0.07% | 44 |
|
|
2019
Q3 | $3.44M | Buy |
67,750
+5,050
| +8% | +$237K | 0.06% | 54 |
|
|
2019
Q2 | $2.84M | Buy |
62,700
+9,455
| +18% | +$440K | 0.06% | 61 |
|
|
2019
Q1 | $2.54M | Buy |
53,245
+2,110
| +4% | +$105K | 0.05% | 64 |
|
|
2018
Q4 | $2.66M | Buy |
51,135
+1,950
| +4% | +$105K | 0.06% | 58 |
|
|
2018
Q3 | $3.05M | Buy |
49,185
+185
| +0.4% | +$11K | 0.05% | 57 |
|
|
2018
Q2 | $2.71M | Buy |
49,000
+5,200
| +12% | +$281K | 0.05% | 55 |
|
|
2018
Q1 | $2.77M | Buy |
43,800
+1,600
| +4% | +$103K | 0.05% | 52 |
|
|
2017
Q4 | $2.59M | Buy |
42,200
+200
| +0.5% | +$12.5K | 0.05% | 57 |
|
|
2017
Q3 | $2.68M | Hold |
42,000
| – | – | 0.06% | 58 |
|
|
2017
Q2 | $2.34M | Sell |
42,000
-900
| -2% | -$49K | 0.07% | 56 |
|
|
2017
Q1 | $2.33M | Buy |
42,900
+7,800
| +22% | +$428K | 0.04% | 69 |
|
|
2016
Q4 | $2.05M | Buy |
35,100
+4,000
| +13% | +$219K | 0.06% | 70 |
|
|
2016
Q3 | $1.68M | Buy |
31,100
+400
| +1% | +$25.7K | 0.06% | 83 |
|
|
2016
Q2 | $2.26M | Buy |
30,700
+200
| +0.7% | +$14.1K | 0.08% | 64 |
|
|
2016
Q1 | $1.95M | Sell |
30,500
-6,200
| -17% | -$391K | 0.06% | 70 |
|
|
2015
Q4 | $2.52M | Buy |
36,700
+2,300
| +7% | +$152K | 0.06% | 52 |
|
|
2015
Q3 | $2.04M | Buy |
34,400
+2,800
| +9% | +$178K | 0.05% | 82 |
|
|
2015
Q2 | $2.1M | Buy |
31,600
+800
| +3% | +$52.7K | 0.05% | 80 |
|
|
2015
Q1 | $1.99M | Sell |
30,800
-8,080
| -21% | -$506K | 0.05% | 82 |
|
|
2014
Q4 | $2.3M | Hold |
38,880
| – | – | 0.06% | 67 |
|
|
2014
Q3 | $1.99M | Sell |
38,880
-5,500
| -12% | -$275K | 0.05% | 85 |
|
|
2014
Q2 | $2.15M | Sell |
44,380
-11,791
| -21% | -$581K | 0.05% | 94 |
|
|
2014
Q1 | $2.92M | Sell |
56,171
-1,100
| -2% | -$58.5K | 0.07% | 76 |
|
|
2013
Q4 | $3.04M | Sell |
57,271
-14,300
| -20% | -$728K | 0.08% | 76 |
|
|
2013
Q3 | $3.31M | Buy |
71,571
+19,400
| +37% | +$852K | 0.1% | 68 |
|
|
2013
Q2 | $2.33M | Buy |
+52,171
| New | +$2.26M | 0.07% | 74 |
|
Other funds holding BMY
New England Asset Management's BMY Position: Q2 2026 in Review
New England Asset Management increased its Bristol-Myers Squibb (BMY) stake by 1.1% in Q2 2026, buying an estimated $24.6K and bringing the position to 40,464 shares worth $2.33M. The position accounts for 0.27% of the portfolio, ranked #76.
New England Asset Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.41M in Q2 2022. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- New England Asset Management held 40,464 shares of Bristol-Myers Squibb worth $2.33M as of Q2 2026.
- New England Asset Management bought 428 Bristol-Myers Squibb shares in Q2 2026, an estimated $24.6K.
- Bristol-Myers Squibb made up 0.27% of New England Asset Management's portfolio in Q2 2026, its #76 holding.
- New England Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- New England Asset Management's Bristol-Myers Squibb position peaked at $8.41M in Q2 2022.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on New England Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.